Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME: Topiramate Monotherapy in Epilepsy
NCT00266604Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2005
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of topiramate in epilepsy, sponsored by Johnson & Johnson. Started Dec 2005; status: completed.
02
Drugs
topiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00266604.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266604.